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Regulation of the CNC-bZIP transcription factor Nrf2 by Keap1 and the axis between GSK-3 and -TrCP Introduction Yuet Wai Kan and colleagues first described NF-E2 p45-related factor 2 (Nrf2, encoded by NFE2L2) when they identified it as the third human cap'n'collar (CNC) basic-region leucine zipper (bZIP) transcription factor to be cloned [1] . Shortly thereafter, Masayuki Yamamoto and colleagues reported an orthologous cDNA from chicken encoding a transcription factor that they called erythroid cell-derived protein with CNC homology (ECH) [2] . The protein is now designated Nrf2, rather than ECH. In mammalian species, Nrf2 regulates the expression of approximately 250 genes, each of which contains an antioxidant response element (ARE, 5-TGACNNNGC-3) sequence in its regulatory region(s) [3, 4] .
Nrf2 is a short-lived transcription factor, but upon exposure to oxidative stressors it is stabilized, rapidly accumulates, and increases transactivation of ARE-driven genes [5] . The instability of Nrf2 protein is largely controlled by Kelch-like ECH-associated protein 1 (Keap1), a redox-sensitive substrate adaptor for the cullin-3 (Cul3)-based ubiquitin ligase CRL Keap1 [6  ,7  ], and a prevailing view is that alleviation of the repression exerted by Keap1 on Nrf2 is entirely responsible for induction of ARE-driven genes by oxidative stressors. It is however much less widely appreciated that Nrf2 is also negatively regulated by glycogen synthase kinase-3 (GSK-3) 1 , and it has been proposed that inhibition of GSK-3 contributes to induction of ARE-driven genes [8  ]. Critically, in this case, GSK-3 is active under normal homeostatic/basal conditions and it phosphorylates a destruction motif in Nrf2 that is recognized by -transducin repeat-containing protein (-TrCP) [9  ], a F-box-containing protein that acts as a substrate adaptor/receptor within the Skp1Cul1F-box (SCF) ubiquitin ligase SCF β-TrCP [10  ,11  ]. Through this joint enterprise between GSK-3 and -TrCP, it is envisaged that inhibition of GSK-3 activity, ostensibly upon cell stimulation by insulin, growth factors or amino acids [12] , diminishes ubiquitylation of Nrf2 by SCF β-TrCP , thereby allowing the transcription factor to accumulate and transactivate ARE-driven genes.
In this 'opinion' article, we describe the dual regulation of Nrf2 by Keap1 and by the combined actions of GSK-3 and -TrCP. In particular, we highlight the putative role played by phosphatase and tensin homolog deleted on chromosome 10 (PTEN) in triggering Keap1independent activation of Nrf2. One distinct possibility is that loss of the phosphatidylinositol (3, 4, 5) -trisphosphate (PIP3) 3-phosphatase activity of PTEN, stimulated by certain inducing agents, results in an increase in the levels of PIP3 that is produced by phosphoinositide 3-kinase (PI3K). As a consequence of increased PIP3 levels, 3-phosphoinositide-dependent protein kinase-1 (PDK1) activity is augmented, which then stimulates protein kinase B (PKB)/Akt signaling [13] . In turn, the increase in PBK/Akt activity (ultimately resulting from PTEN inhibition) leads to phosphorylation of an N-terminal Ser residue in GSK-3 that causes loss of its kinase activity, and thus an increase in the abundance of Nrf2 and induction of ARE-driven genes. Through its ability to increase PDK1 activity, via production of PIP3, PI3K may also repress GSK-3 activity by stimulating p70 ribosomal S6 kinase (p70 S6K ), p90 ribosomal S6 kinase (p90 RSK ) and certain protein kinase C (PKC) isoforms [14-16], and the possible regulation of Nrf2 by these pathways that lie downstream of PI3K is also discussed briefly.
Positive regulation of gene expression by Nrf2

Nrf2 targets antioxidant and detoxication genes in normal cells
In normal non-transformed cells, Nrf2 positively regulates the basal and/or stressinducible expression of many ARE-driven antioxidant genes ( 
Constitutive activation of Nrf2 in cancer cells increases anabolic metabolism
In non-small cell lung cancer (NSCLC) cell lines in which repression of Nrf2 by Keap1 is lost as a consequence of somatic mutations in Keap1 or NFE2L2, the resulting high levels of Nrf2 activity can increase anabolic metabolism if its up-regulation coincides with a growth stimulus, such as sustained activation of PI3K [21  ]; PI3K pathway alterations in cancer are associated with somatic mutations in a number of oncogenes including EGFR, HER2, MET and RAS [22, 23] . Under these circumstances, Nrf2 orchestrates overexpression of G6PD, PGD, TKT and TALDO1 (involved in the pentose phosphate pathway), along with PPAT and MTHFD2 (involved in purine synthesis), and results in glucose being redirected away from glycolysis towards ribose-5-phosphate and nucleotide production [21  ]. In addition, such circumstances result in overexpression of ME1 and IDH1, which along with G6PD and PGD are involved in generation of NADPH that is required for synthesis of macromolecules; these genes have all been reported to contain ARE sequences [21  ]. High Nrf2 activity in NSCLC cells also results in the glycolytic intermediate 3-phosphoglycerate being channeled towards serine biosynthesis by increasing the activity of activating transcription factor 4 (ATF4), which in turn induces expression of PHGDH, PSAT1, PSPH, SHMT1 and SHMT2 [24  ]. These findings suggest that in cancer cells, constitutive up-regulation of Nrf2 in conjunction with activation of the PI3K pathway, increases macromolecule synthesis and promotes tumorigenesis.
Repression of Nrf2 by Keap1
Because many xenobiotic inducers of NQO1 and GST enzyme activities contain a thiol-reactive electrophilic moiety (i.e. are soft electrophiles), Paul Talalay and colleagues predicted in 1988 that they would be recognized within the cell through reaction with sulfhydryl groups in a 'sensor' protein [25] . Thus following the discovery that Nrf2 mediates basal and/or inducible expression of Nqo1 and Gsta1 in mice [26  ,27], it seemed possible that Nrf2 activity would be regulated through a 'sensor' protein that contains unique thiol groups. Besides forming adducts with xenobiotics, Cys-216 and Cys-613 in Keap1 can form an intramolecular disulfide bridge following exposure to H2O2, and this is thought to contribute to activation of Nrf2 by reactive oxygen species (ROS) [36, 37] . Importantly, inducing agents stimulate conformational changes in the complex formed between Keap1 and Nrf2 that block ubiquitylation of the transcription factor by CRL Keap1 [38] .
Control of Nrf2 via the combined actions of the PTENGSK-3 pathway and -TrCP
Evidence that the PI3KPKB/AktGSK-3 pathway regulates Nrf2
Jeffrey Johnson and colleagues first reported that the PI3K inhibitor LY294002 suppressed basal and tBHQ-stimulated Nrf2 activity in human IMR-32 neuroblastoma cells 6 [39  ,40] but the observation was largely ignored because it could not be accommodated within the canonical 'Keap1-Nrf2 pathway'. The notion that PI3K contributes to Nrf2-mediated gene induction was confirmed by Antonio Cuadrado and colleagues, who showed that pre-treatment of rat PC-12 pheochromocytoma cells with LY294002 substantially attenuates the ability of carnosol to increase endogenous Nrf2 protein levels and induce HMOX1 [41  ]. Subsequently, Salazar at el [8  ] demonstrated that PI3K increases Nrf2 activity by stimulating PKB/Akt, which in turn inhibits GSK-3. They also provided evidence, using ectopic expression of constitutively active and dominant negative mutants, that GSK-3 activity prevents nuclear accumulation of Nrf2. In this context, it should be noted that GSK-3 is active in cells under normal conditions, and PKB/Akt is one amongst a number of protein kinases that inhibit GSK-3 by catalyzing phosphorylation of Ser-9 and Ser-21 in GSK-3 and GSK-3, respectively [42  ,43]; note, GSK-3 can also be inhibited by p70 S6K , p90 RSK and PKC [12, 44] , and all of these are regulated by PI3K through PDK1 [14-16, 45, 46] .
Besides tBHQ and carnosol, other chemoprotective agents induce HMOX1 and NQO1
through an Nrf2-mediated mechanism that is sensitive to inhibition by LY294002. These include curcumin, ferulic acid, 1[2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole (CDDO-Im) 2 , 4,17(20)-(cis)-pregnadiene-3,16-dione (E-guggulsterone) and nordihydroguaiaretic acid (see Figure 1 for structures of inducers) [47,48,49  ,50,51] . By analogy with carnosol [8  ], it seems plausible that these inducers also stimulate PKB/Akt and inactivate GSK-3. This prediction is not however supported by Lee et al [39  ], who reported that treatment of IMR-32 cells with tBHQ did not activate PKB/Akt or increase inhibitory phosphorylation of GSK-3 whereas treatment with insulin did. By contrast, treatment of mouse embryonic fibroblasts (MEFs) with tBHQ has been reported to stimulate PKB/Akt and cause phosphorylation of GSK-3 at Ser-21/9 [52] . It is not known whether this discrepancy is due to experimental differences or to intrinsic properties of IMR-32 cells and MEFs.
Evidence that PTEN and DJ-1 are 'sensor' proteins for agents that induce Nrf2-target genes It is uncertain why xenobiotics that increase ARE-driven gene expression in a LY294002-sensitive manner are dependent on PI3K for their inducer activity. However, as a biotinylated analogue of CDDO-Im has been shown to activate the PI3KPKB/Akt pathway by modifying covalently Cys-124 in the active center of PTEN [49  ], it is possible that other LY294002-sensitive inducers of Nrf2-target genes similarly inhibit the PIP3 3-phosphatase activity of PTEN and in so doing stimulate Nrf2 activity via the PI3KPKB/AktGSK-3 pathway. Consistent with this idea, the ability of E-guggulsterone to increase Nrf2 protein 7 abundance and induce HMOX1 in MCF-10A cells is substantially attenuated by forced overexpression of a PTEN C124S mutant [50] . Moreover, 4-hydroxynonenal, which has been reported to induce Nrf2-target genes, is also capable of modifying Cys-71 in PTEN [53] .
Within cells, the Cys-71 and Cys-124 residues in PTEN form a disulfide bridge upon treatment with H2O2 and peptide growth factors, causing inactivation of the PIP3 3-phosphatase and an increase in PKB/Akt activity [13] . It is therefore reasonable to suppose that modification of Cys-71 and/or Cys-124 in PTEN will inhibit its phosphatase activity. The hypothesis that PTEN acts indirectly to repress Nrf2 is supported by the findings that the activity of Nrf2 is suppressed in MEFs that overexpress PTEN and also in PC-12 cells that ectopically express a PTEN-estrogen receptor fusion protein that can be activated by 4-hydroxytamoxifen [54] . Thus like Keap1, PTEN may serve as a 'sensor' of electrophiles and oxidative stressors within cells.
The proposed 'sensor' role for PTEN that controls Nrf2 via the PI3KPKB/AktGSK-3 pathway raises the possibility that the Parkinsonism-associated protein DJ-1 attenuates this mode of regulation because it is a multifunctional protein that negatively controls PTEN [55, 56] ; the functions of DJ-1 include atypical peroxiredoxin-like peroxidase activity [57] and metal binding [58] . Most importantly, knockdown of DJ-1 has been reported to suppress Nrf2 activity, but as this was discovered before the concept that the PI3KPKB/Akt pathway regulates Nrf2 gained traction, it was thought that DJ-1 increases Nrf2 activity by antagonizing Keap1 [59] . It now seems more likely that DJ-1 dampens the ability of PTEN to prevent the PI3KPKB/Akt pathway from stimulating Nrf2 activity, rather than it antagonizing Keap1. An interesting point is that DJ-1 contains some reactive thiol groups that can be modified by ROS, including Cys-46, Cys-53 and Cys-106 [60] , with Cys-46 and Cys-53 being susceptible to Snitrosylation [61] , and so it too might act as a 'sensor' protein. Intriguingly, DJ-1 may act as an adjunct 'sensor' by transferring nitric oxide from Cys-106 in DJ-1 onto Cys residues in PTEN, in a manner that results in loss of the PIP3 3-phosphatase activity of the latter protein [62] .
Repression of Nrf2 by GSK-3 through the actions of -TrCP
It was initially proposed that repression of Nrf2 by GSK-3 involves nuclear exclusion of the transcription factor [8  ], possibly following its phosphorylation by Fyn (downstream of GSK-3) and/or increased turnover of the transcription factor by Keap1 [63, 64] . However, in a separate line of investigation, deletion analyses indicated that two regions within the Neh6 
Certain, but not all, inducers that activate Nrf2 antagonize both Keap1 and GSK-3
Evidence suggests that tBHQ may simultaneously inhibit the Keap1-directed ubiquitylation of Nrf2 and the phosphorylation of Nrf2 by GSK-3 [52] . It is not however clear whether other inducing agents antagonize both Keap1 and GSK-3. To examine this possibility, and test whether antagonism of GSK-3 entails activation of PI3K and PKB/Akt, we treated Keap1 -/and Keap1 +/+ MEFs with tBHQ or diethyl maleate (DEM), with the latter chosen because it is a potent inducing agent that has been employed in gene expression profiling and chromatin immunoprecipitation combined with high-throughput DNA sequencing [4,28  ]. As anticipated, immunoblotting showed that the basal level of mRNAs for both Hmox1 and Nqo1 is higher in Keap1 -/than Keap1 +/+ fibroblasts. Treatment of Keap1 +/+ fibroblasts with tBHQ ( Figure 2A Figure 2C ).
However, unlike the situation with tBHQ and DEM, treatment of Keap1 -/-MEFs with SFN did not increase further the elevated basal levels of Hmox1 or Nqo1 mRNA in the mutant fibroblasts; similar results have been observed by workers in the laboratory of Antonio Cuadrado 3 . This implies that certain inducing agents inhibit Keap1 but not GSK-3.
Concluding comments and future directions
This article provides an overview of the mechanisms by which Nrf2 is repressed by CRL Keap1 and by GSK-3. We have also presented evidence that tBHQ and DEM can induce Hmox1 and Nqo1 through a Keap1-independent mechanism, and that the GSK-3 inhibitor CT99021 can also stimulate Keap1-independent induction of Hmox1 and Nqo1. We speculate that inducing agents may modify Cys-46, Cys-53 and Cys-106 in DJ-1, and/or Cys-71 and Cys-124 in PTEN, and in so doing cause inhibition of GSK-3 by increasing PIP3-based PDK1 signaling that results in activation of PKB/Akt, thereby preventing formation of the DSGIS-containing phosphodegron in Nrf2 (Figure 3 ). The possibility that the positive regulation of Nrf2 by PI3K via GSK-3 might be mediated, at least in part, by kinases other that PKB/Akt, such as p70 S6K , p90 RSK An important area that needs to be addressed in future concerns the priming of Nrf2 for phosphorylation by GSK-3. In particular, GSK-3 substrates usually have to be phosphorylated (i.e. primed) by another protein kinase before GSK-3 is able to phosphorylate them [69  ].
Further work is required to identify protein kinases that prime Nrf2 for phosphorylation by GSK-3. 10  . Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW. The SCF β-TrCPubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IB and -catenin and stimulates IB ubiquitination in vitro. Genes Dev. 1999, 13:270-83.
One of several papers published in close succession reporting -TrCP to be an adaptor protein for cullin-1. 
Graphical Abstract
The cartoon depicts the approximate increases in Nrf2 activity, and the resulting induction of antioxidant and detoxication cytoprotective genes (such as Gclc, Gclm, Gpx2, Hmox1, Nqo1, Srxn1 and Txnrd1) compared with metabolic genes (such as G6pdx, Me1, Mthfd2, Pgd and This table has been compiled from information contained in references 3, 4, 17 and 18. Please note that in the column designated 'Name of gene', the abbreviation "p" (against genes CYP1B1, CYP2B9, GSTA1, GSTM1, GSTP1, UGT1A1 and UGT2B7) signifies "polypeptide". Under the column designated 'Function of gene product' the abbreviations are as follows: 4-HNE, 4-hydroxy-2-nonenal; PG, prostaglandin; PAH, polycyclic aromatic hydrocarbon. Under the column designated 'Species', m signifies mouse, and h signifies human. [60, 61] . Alternatively, amino acids can stimulate the mTORp70 S6K pathway and inhibit 14, 15] , and this represents another mechanism by which repression of Nrf2 by GSK-3 might be alleviated (see top right-hand side of cartoon). In all of these instances, the resulting loss of GSK-3 activity causes a decrease in phosphorylation of the DSGIS motif in the Neh6 domain of Nrf2, which is recognized by -TrCP, and so diminishes ubiquitylation of Nrf2 by SCF β-TrCP , allowing accumulation of the transcription factor and induction of its target genes [9  ,66,67  ]. It should be noted that by comparison with other substrates [69  ], it is probable that GSK-3 requires Nrf2 to be phosphorylated by another 'priming' kinase before it is able to phosphorylate the transcription factor within the DSGIS motif, which introduces a further tier of regulation. The genes that are induced following inhibition of Keap1 differ from those activated upon inhibition of PTEN [21  ,68] . As shown in the bottom left-hand part of the cartoon, induction of ARE-driven genes upon inhibition of Keap1 augments antioxidant and detoxication capacity, which allows adaptation to exposure to oxidative stressors.
